Business

Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First Subject

Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First Subject

articleSuzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASeptember 16, 20253/news/announcement-on-voluntary-disclosure-of-the-conduct-of-key-clinical-trials-for-zg006-for-injection-and-completion-of-the-enrollment-of-the-first-subject
Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First Subject

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First SubjectThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A